Inhibition of drug-metabolizing enzyme activity in human hepatic cytochrome P450s by bisphenol A

Biol Pharm Bull. 2000 Apr;23(4):498-501. doi: 10.1248/bpb.23.498.

Abstract

Effect of bisphenol A on drug-metabolizing enzyme activities by human hepatic cytochrome P450s (CYP) was investigated. We measured aminopyrine N-demethylation by eleven kinds of cDNA-expressed CYPs. CYP2C19 and CYP2B6 catalyzed most efficiently the aminopyrine N-demethylation, followed by CYP2C8 and CYP2D6. Bisphenol A (1 mM) most efficiently inhibited aminopyrine N-demethylation by CYP2C8 and CYP2C19 by 82% and 85%, respectively, whereas inhibition of the activities by CYP 2B6 and 2D6 was less than 40%. Bisphenol A exhibited a noncompetitive-type inhibition of aminopyrine N-demethylase activity by CYP2C8 with Ki value of 97 microM. Additionally, we investigated the inhibitory effect of bisphenol A on CYP2C19-mediated S-mephenytoin 4-hydroxylation. Bisphenol A exhibited a mixed-type inhibition with Ki value of 113 microM. These results suggest that bisphenol A inhibits human hepatic CYP activities, especially CYP2C8 and CYP2C19.

MeSH terms

  • Benzhydryl Compounds
  • Biotransformation
  • Cytochrome P-450 Enzyme Inhibitors*
  • Cytochrome P-450 Enzyme System / metabolism
  • Humans
  • Microsomes, Liver / enzymology*
  • Phenols / pharmacology*
  • Recombinant Proteins / antagonists & inhibitors
  • Recombinant Proteins / metabolism

Substances

  • Benzhydryl Compounds
  • Cytochrome P-450 Enzyme Inhibitors
  • Phenols
  • Recombinant Proteins
  • Cytochrome P-450 Enzyme System
  • bisphenol A